Gastroenterology — MCQs

A 45-year-old woman presents with a 1-week history of jaundice, anorexia, and right upper quadrant discomfort. On examination she is icteric, with a tender right upper quadrant and liver span of 14 cm. She reports consuming one bottle of wine a day for the past 6 months. Which of the following laboratory test findings is most likely to be characteristic of a patient with jaundice secondary to alcoholic hepatitis?

Q179Easy

Alpha chain disease is detected by?

Q180Medium

Which of the following is NOT a complication of acute viral hepatitis?

Gastroenterology Indian Medical PG Practice Questions and MCQs

Question 171: What is capsule endoscopy used for?

A. Gastrointestinal bleeding (Correct Answer)
B. Motility disorders
C. Gastroesophageal reflux disease (GERD)
D. None of the above

Explanation: **Explanation:** **Capsule Endoscopy (Wireless Capsule Endoscopy)** is a non-invasive diagnostic tool primarily used to visualize the **small intestine** [2], an area traditionally difficult to reach via standard upper GI endoscopy [1] or colonoscopy [2]. **Why Option A is correct:** The most common and established indication for capsule endoscopy is **Obscure Gastrointestinal Bleeding (OGIB)** [3]. When a patient presents with iron deficiency anemia or melena, and both upper endoscopy and colonoscopy fail to identify a source, capsule endoscopy is the "gold standard" for detecting small bowel lesions such as **angiodysplasias** (most common cause) [3], Crohn’s disease, or small bowel tumors. **Why other options are incorrect:** * **B. Motility disorders:** While the transit time of the capsule can be measured, it is not the primary diagnostic modality for motility disorders. Specialized tests like **manometry** or gastric emptying studies (scintigraphy) are preferred. * **C. GERD:** GERD is a clinical diagnosis or confirmed via **24-hour pH monitoring** and upper GI endoscopy (to check for Barrett’s esophagus or esophagitis). A capsule moving rapidly through the esophagus cannot provide the detailed mucosal biopsy or prolonged monitoring required. **High-Yield Clinical Pearls for NEET-PG:** * **Contraindication:** The absolute contraindication is **intestinal obstruction** or known strictures (risk of capsule retention). * **Other Indications:** Surveillance of polyposis syndromes (e.g., Peutz-Jeghers) and assessing the extent of small bowel Crohn’s disease. * **Patency Capsule:** If a stricture is suspected, a "Patency Capsule" (dissolvable) is used first to ensure the real capsule will pass safely.

Question 172: All of the following are true regarding osmotic diarrhea EXCEPT:

A. Caused by ingestion of poorly absorbed, highly osmotic substances in the intestinal lumen.
B. Symptoms may improve with fasting, as the osmotic load is reduced.
C. Stool typically contains reducing substances, indicating unabsorbed carbohydrates.
D. Can be mediated by bacterial toxins that stimulate fluid secretion. (Correct Answer)

Explanation: **Explanation:** The core concept in differentiating types of diarrhea lies in the mechanism of fluid movement. **Why Option D is the correct answer (The "Except"):** Option D describes **Secretory Diarrhea**, not osmotic diarrhea [2]. Secretory diarrhea is mediated by secretagogues—such as bacterial toxins (e.g., *Vibrio cholerae* enterotoxin), hormones (e.g., VIPoma), or bile acids—that stimulate the active secretion of electrolytes (mainly $Cl^-$) and water into the intestinal lumen. Unlike osmotic diarrhea, secretory diarrhea is independent of food intake and persists during fasting. **Analysis of Incorrect Options (True statements regarding Osmotic Diarrhea):** * **Option A:** This is the definition of osmotic diarrhea. It occurs when non-absorbable, water-soluble solutes (like lactulose, magnesium salts, or polyethylene glycol) remain in the bowel, creating an osmotic gradient that pulls water into the lumen [1]. * **Option B:** Since the diarrhea is driven by ingested substances, **fasting** (stopping the intake of the offending solute) typically leads to a significant reduction or cessation of stool output [1]. * **Option C:** In cases of carbohydrate malabsorption (e.g., Lactase deficiency), unabsorbed sugars are fermented by colonic bacteria [1]. This produces **reducing substances** and lowers the stool pH ($<5.5$). **NEET-PG High-Yield Pearls:** 1. **Stool Osmotic Gap (SOG):** This is the gold standard for differentiation. * **Osmotic Diarrhea:** High SOG ($>125$ mOsm/kg). * **Secretory Diarrhea:** Low SOG ($<50$ mOsm/kg). * *Formula:* $290 - 2 \times (\text{Stool } Na^+ + \text{Stool } K^+)$. 2. **Stool Volume:** Secretory diarrhea often presents with massive volumes ($>1$ L/day), whereas osmotic diarrhea is usually $<1$ L/day. 3. **Common Causes:** Osmotic (Lactulose, Milk of Magnesia, Celiac disease); Secretory (Cholera, ETEC, Carcinoid syndrome, VIPoma).

Question 173: Toxic megacolon is a known complication of which of the following conditions?

A. Pseudomembranous colitis
B. Ulcerative colitis (Correct Answer)
C. Amebic colitis
D. Hirschsprung's disease

Explanation: **Explanation:** **Toxic Megacolon** is a life-threatening complication characterized by total or segmental non-obstructive colonic dilatation (usually >6 cm) associated with systemic toxicity. **1. Why Ulcerative Colitis (UC) is the correct answer:** UC is the most common cause of toxic megacolon. The underlying pathophysiology involves severe transmural inflammation that reaches the muscularis propria [1]. This leads to the release of excessive **nitric oxide** and inflammatory mediators, which inhibit smooth muscle tone and cause neuromuscular paralysis of the colon. This results in rapid dilatation and a high risk of perforation. **2. Analysis of Incorrect Options:** * **Pseudomembranous colitis (*C. difficile*):** While it can occasionally cause toxic megacolon, it is less common than UC. In the context of standard medical exams, UC remains the primary association. * **Amebic colitis:** Though it causes deep flask-shaped ulcers and can lead to perforation, it rarely presents as classic toxic megacolon. * **Hirschsprung's disease:** This is a congenital condition caused by the absence of ganglion cells [2]. It leads to a "functional" megacolon (proximal to the aganglionic segment) but is not typically classified under "toxic megacolon," which implies an acute inflammatory/infectious etiology with systemic toxicity [2]. **3. High-Yield Clinical Pearls for NEET-PG:** * **Diagnostic Criteria:** Jalan’s Criteria (Radiological evidence of dilatation >6 cm + 3 of: Fever >101.5°F, HR >120, WBC >10,500, or Anemia). * **Triggers:** Use of antimotility agents (loperamide), opioids, or recent colonoscopy in a patient with active colitis. * **Management:** Initial management is medical (NPO, IV fluids, IV steroids, and broad-spectrum antibiotics). If no improvement in 24–72 hours, **emergency subtotal colectomy with ileostomy** is the treatment of choice. * **X-ray finding:** Look for "Thumbprinting" (mucosal edema) and loss of haustral markings.

Question 174: Which of the following features is associated with Irritable Bowel Syndrome?

A. Weight loss
B. Anorexia
C. Abdominal distension (Correct Answer)
D. Blood in stool

Explanation: Irritable Bowel Syndrome (IBS) is a **functional gastrointestinal disorder** characterized by chronic abdominal pain and altered bowel habits in the absence of organic pathology [1]. **Why Abdominal Distension is Correct:** Abdominal distension and bloating are hallmark features of IBS, reported by up to 60-90% of patients [1]. The underlying pathophysiology involves **visceral hypersensitivity**, altered gut motility, and abnormal gas handling or gut microbiota (dysbiosis). While the physical girth may not always increase significantly, the *sensation* of bloating and visible distension (often worsening throughout the day) are classic diagnostic clues [1]. **Why Other Options are Incorrect:** Options A, B, and D are considered **"Red Flag" or "Alarm Symptoms."** Their presence should prompt an investigation for organic diseases (such as Malignancy, Inflammatory Bowel Disease, or Celiac Disease) rather than a diagnosis of IBS [1]: * **Weight Loss (A) & Anorexia (B):** These suggest systemic illness, malabsorption, or malignancy. IBS is a functional disorder and does not typically cause significant weight loss [1]. * **Blood in Stool (D):** Hematochezia indicates mucosal inflammation, ulceration, or neoplasia. IBS does not cause bleeding [1]. **NEET-PG High-Yield Pearls:** * **Rome IV Criteria:** The current gold standard for diagnosis. Requires recurrent abdominal pain (at least 1 day/week in the last 3 months) associated with 2 or more of: 1. Related to defecation, 2. Change in frequency of stool, 3. Change in form (appearance) of stool. * **Manning Criteria:** Specifically includes "visible abdominal distension" as a key clinical feature. * **Pain Relief:** In IBS, abdominal pain is typically **relieved by defecation** [1] and does not occur at night (nocturnal pain is an alarm symptom) [1].

Question 175: Which of the following statements about peptic ulcer disease is true?

A. Helicobacter pylori eradication increases the likelihood of complications.
B. The incidence of hospitalizations for peptic ulcer disease has reduced. (Correct Answer)
C. The incidence of Helicobacter pylori infection in India is very low.
D. Helicobacter pylori eradication does not alter the recurrence ratio.

Explanation: **Explanation:** The epidemiology of Peptic Ulcer Disease (PUD) has shifted significantly over the last few decades due to better diagnostic tools and effective treatments. **Why Option B is Correct:** The incidence of hospitalizations for PUD has **markedly reduced** globally [1]. This trend is attributed to two major factors: the discovery and widespread treatment of *Helicobacter pylori* and the introduction of potent acid-suppressing medications like Proton Pump Inhibitors (PPIs) [1]. While complications like perforation still occur (often due to NSAID use), the overall burden of elective and emergency admissions for uncomplicated ulcers has declined [1]. **Analysis of Incorrect Options:** * **Option A:** *H. pylori* eradication significantly **decreases** the likelihood of complications such as bleeding and perforation [1]. It is the cornerstone of preventing ulcer-related morbidity. * **Option C:** The incidence of *H. pylori* in India is **very high** (estimated between 60-80%), not low. It is typically acquired in childhood due to socio-economic factors and overcrowding [2]. * **Option D:** Eradication of *H. pylori* **dramatically alters** the recurrence ratio [1]. Without eradication, ulcer recurrence rates are 60-90%; with successful eradication, the recurrence rate drops to less than 10-20% [1]. **High-Yield Clinical Pearls for NEET-PG:** * **Most common cause of PUD:** *H. pylori* infection (followed by NSAIDs). * **Most common site for H. pylori colonization:** Gastric Antrum [2]. * **Investigation of choice (Gold Standard):** Endoscopic biopsy followed by Rapid Urease Test (RUT) or Histopathology [1]. * **Non-invasive Test of Choice (for confirmation of eradication):** Urea Breath Test (UBT) [1]. * **First-line Treatment:** Clarithromycin-based Triple Therapy (PPI + Amoxicillin + Clarithromycin) for 14 days.

Question 176: A diagnosis of chronic hepatitis is made if liver disease is present for a minimum of:

A. 3 weeks
B. 6 weeks
C. 6 months (Correct Answer)
D. 3 months

Explanation: **Explanation:** The diagnosis of **chronic hepatitis** is defined by the presence of clinical, biochemical, or serological evidence of liver inflammation and necrosis for a **minimum of 6 months** [1]. This timeframe is the standard clinical threshold used to differentiate acute liver injury from chronic disease. * **Why 6 months is correct:** In most cases of acute viral hepatitis (such as Hepatitis B), the body’s immune system typically clears the virus or resolves the inflammation within 3 to 6 months. Persistence beyond the 6-month mark indicates that the immune system has failed to clear the insult, leading to potential progressive fibrosis and cirrhosis [1]. **Analysis of Incorrect Options:** * **3 weeks & 6 weeks (Options A & B):** These durations fall strictly within the **acute phase** of hepatitis [1]. Most acute infections show peak transaminase levels and symptomatic presentation within this window. * **3 months (Option D):** While some guidelines for specific conditions (like certain drug-induced liver injuries) monitor progress at 3 months, the universal definition for "chronic" hepatitis across major textbooks (Harrison’s, Davidson’s) remains 6 months. **High-Yield Clinical Pearls for NEET-PG:** * **Hepatitis B:** Persistence of **HBsAg for >6 months** is the hallmark of chronic HBV infection [1]. * **Hepatitis C:** Unlike HBV, HCV has a high chronicity rate; approximately **80%** of acute infections progress to chronic hepatitis. * **Hepatitis E:** Generally causes acute hepatitis, but can become **chronic in immunocompromised patients** (e.g., organ transplant recipients). * **Hepatitis A & D:** Hepatitis A **never** causes chronic disease. Hepatitis D only becomes chronic if it occurs as a co-infection or super-infection with Hepatitis B.

Question 177: Which of the following statements regarding Ulcerative Colitis is FALSE?

A. Smoking may prevent the disease
B. There is 58% concordance with monozygotic twins (Correct Answer)
C. There is 0% concordance with dizygotic twins
D. Appendectomy is protective for the disease

Explanation: The correct answer is **B** because the statement is factually incorrect regarding the genetic epidemiology of Ulcerative Colitis (UC). **1. Why Option B is the Correct Answer (The False Statement):** In Ulcerative Colitis, the concordance rate among monozygotic (identical) twins is significantly lower than in Crohn’s Disease. For UC, the concordance rate is approximately **6% to 16%**, whereas for Crohn’s Disease, it is much higher (around 50-58%). The figure "58%" mentioned in the option actually refers to the concordance rate for Crohn’s Disease, not UC. **2. Analysis of Other Options:** * **Option A (Smoking):** This is a true statement. Smoking has a paradoxical protective effect in UC. Active smokers are at a lower risk of developing UC, and smoking cessation can sometimes trigger a flare-up of the disease. (Note: The opposite is true for Crohn’s, where smoking worsens the disease). * **Option C (Dizygotic twins):** This is generally considered true. The concordance rate for dizygotic twins in UC is extremely low, often cited as **0% to 2%**, highlighting that while there is a genetic component, environmental factors play a massive role. * **Option D (Appendectomy):** This is a true statement. Epidemiological studies show that an appendectomy performed at a young age (especially for true appendicitis) significantly reduces the risk of developing UC later in life. **High-Yield Clinical Pearls for NEET-PG:** * **UC vs. Crohn’s Genetics:** Crohn’s has a much stronger genetic association (higher twin concordance) than UC. * **Protective Factors for UC:** Smoking and Appendectomy. * **Pathology:** UC involves **continuous** mucosal inflammation starting from the rectum (proctitis) and extending proximally, whereas Crohn’s is characterized by **skip lesions** and transmural involvement [1]. * **Serology:** UC is associated with **p-ANCA**, while Crohn’s is associated with **ASCA**.

Question 178: A 45-year-old woman presents with a 1-week history of jaundice, anorexia, and right upper quadrant discomfort. On examination she is icteric, with a tender right upper quadrant and liver span of 14 cm. She reports consuming one bottle of wine a day for the past 6 months. Which of the following laboratory test findings is most likely to be characteristic of a patient with jaundice secondary to alcoholic hepatitis?

A. AST : ALT ratio of 3:1 and AST is 500 U/L
B. AST : ALT ratio of 2:1 and AST is 250 U/L (Correct Answer)
C. AST : ALT ratio of 1:1 and AST is 500 U/L
D. AST : ALT ratio of 1:1 and AST is 250 U/L

Explanation: ### Explanation The clinical presentation of jaundice, tender hepatomegaly, and significant alcohol consumption is classic for **Alcoholic Hepatitis**. [1] **1. Why Option B is Correct:** In alcoholic hepatitis, the pattern of liver enzyme elevation is highly characteristic: * **AST:ALT Ratio:** Typically **>2:1**. This occurs because alcohol induces mitochondrial AST isoenzymes while simultaneously causing a deficiency in **Pyridoxal-5'-phosphate (Vitamin B6)**. Since ALT synthesis is more dependent on Vitamin B6 than AST, ALT levels remain disproportionately low. [1] * **Absolute Values:** Unlike viral or drug-induced hepatitis, the AST in alcoholic hepatitis is rarely very high. [1] It is almost always **<300–500 U/L**. A value of 250 U/L fits perfectly within this clinical window. [1] **2. Why Other Options are Incorrect:** * **Options A & C:** While an AST:ALT ratio of 3:1 is possible, an AST level of **500 U/L** is atypical for alcoholic hepatitis. [1] Levels above 500 U/L should prompt a search for other etiologies like viral hepatitis, autoimmune hepatitis, or ischemic injury ("shock liver"). [1] * **Option D:** A 1:1 ratio is more common in **NAFLD** (Non-Alcoholic Fatty Liver Disease) or chronic viral hepatitis. [1] **3. NEET-PG High-Yield Pearls:** * **Maddrey Discriminant Function (DF):** Used to assess severity. Formula: $4.6 \times [PT_{patient} - PT_{control}] + \text{Serum Bilirubin}$. If **DF >32**, it indicates severe hepatitis and a high risk of mortality; corticosteroids (Prednisolone) are the treatment of choice. * **Histology:** Look for **Mallory-Denk bodies** (eosinophilic intracytoplasmic inclusions) and "chicken-wire" fibrosis (perivenular/pericellular fibrosis). * **Leukemoid Reaction:** Alcoholic hepatitis often presents with a high WBC count (neutrophilia), mimicking an infection.

Question 179: Alpha chain disease is detected by?

A. M component in serum
B. Jejunal biopsy (Correct Answer)
C. Light chain in lumen of jejunum
D. All of the above

Explanation: **Explanation:** **Alpha Chain Disease (Immunoproliferative Small Intestinal Disease - IPSID)** is a variant of MALT lymphoma characterized by the proliferation of B-lymphocytes that secrete an incomplete IgA heavy chain (alpha chain) lacking light chains. **Why Jejunal Biopsy is the Correct Answer:** The definitive diagnosis of Alpha Chain Disease is made via **jejunal biopsy**. Histopathology typically reveals a dense, diffuse mucosal infiltration of the lamina propria with plasma cells and lymphocytes. This infiltration leads to villous atrophy and malabsorption. While the abnormal alpha chains can sometimes be found in secretions, the gold standard for confirming the lymphoproliferative nature and the extent of the disease is the tissue biopsy. **Analysis of Incorrect Options:** * **Option A (M component in serum):** In Alpha Chain Disease, a classic "M-spike" (monoclonal peak) is usually **absent** on standard serum protein electrophoresis (SPEP). This is because the truncated alpha chains are heterogeneous in size (due to polymer formation) and often present as a broad band rather than a sharp spike. * **Option C (Light chain in lumen):** By definition, Alpha Chain Disease is a **heavy chain disease**. The plasma cells produce truncated alpha heavy chains *without* associated light chains. Therefore, light chains will not be found in the jejunal lumen. **High-Yield Clinical Pearls for NEET-PG:** * **Epidemiology:** Most common in young adults (20–30s) from the Mediterranean, Middle East, and North Africa. * **Clinical Presentation:** Chronic diarrhea, malabsorption, weight loss, and abdominal pain. * **Association:** Strongly linked to chronic infection with ***Campylobacter jejuni***; early stages may respond to antibiotics (Tetracycline). * **Diagnosis:** Immunofixation electrophoresis of serum or intestinal secretions showing free alpha heavy chains.

Question 180: Which of the following is NOT a complication of acute viral hepatitis?

A. Aplastic anemia
B. Acute pancreatitis
C. Autoimmune hepatitis
D. Hepatocellular carcinoma (Correct Answer)

Explanation: **Explanation:** The correct answer is **D. Hepatocellular carcinoma (HCC)**. The distinction lies in the timeline of the disease process. **Acute viral hepatitis** refers to a sudden, short-term inflammation of the liver (most commonly caused by Hepatitis A or E) [1]. **Hepatocellular carcinoma** is a complication of **chronic** liver disease, typically arising after years of chronic inflammation, cirrhosis, and genomic instability caused by Chronic Hepatitis B or C. It does not occur as a complication of an acute, self-limiting infection. **Analysis of Incorrect Options:** * **A. Aplastic anemia:** This is a rare but well-recognized extrahepatic complication of acute viral hepatitis (often termed "Hepatitis-associated aplastic anemia"). It typically occurs 2–3 months after the acute phase. * **B. Acute pancreatitis:** Though uncommon, acute pancreatitis can occur as a complication of acute viral hepatitis (especially Hepatitis A, B, and E) due to direct viral invasion or edema of the Ampulla of Vater. * **C. Autoimmune hepatitis:** Acute viral infections (like HAV or HBV) can act as environmental triggers that "unmask" or induce autoimmune hepatitis in genetically susceptible individuals through molecular mimicry. **High-Yield Pearls for NEET-PG:** * **Fulminant Hepatic Failure:** The most dreaded acute complication, most common with HBV (especially with HDV co-infection) and HEV (in pregnant women) [2]. * **Extrahepatic manifestations:** Look for serum sickness-like syndrome (HBV), cryoglobulinemia (HCV), and polyarteritis nodosa (HBV). * **Aplastic Anemia:** Usually presents with pancytopenia following a bout of hepatitis; it is often severe and carries a high mortality rate if not treated with bone marrow transplant or immunosuppression.

Practice by Chapter

Esophageal Disorders

Practice Questions

Peptic Ulcer Disease

Practice Questions

Inflammatory Bowel Disease

Practice Questions

Irritable Bowel Syndrome

Practice Questions

Malabsorption Syndromes

Practice Questions

Pancreatitis (Acute and Chronic)

Practice Questions

Gastrointestinal Bleeding

Practice Questions

Liver Diseases and Cirrhosis

Practice Questions

Viral Hepatitis

Practice Questions

Biliary Tract Disorders

Practice Questions

Gastrointestinal Motility Disorders

Practice Questions

Gastrointestinal Malignancies

Practice Questions

Want unlimited practice?

Get full access to all questions, explanations, and performance tracking.

Start For Free